A Phase I Study of AG-221 in Patients with Advanced Acute Myeloid Leukemia or Myelodysplastic Syndromes with an IDH2 Mutation | Clinical Trial
Your Memorial Sloan Kettering physician can help you decide whether treatment through a clinical trial is right for you. Sometime clinical trials should be considered as the first treatment for myelodysplastic syndromes (MDS). If you have already received standard treatments, then clinical trials may be an option to consider in addition to supportive care.
Here you can find a continually updated listing of Memorial Sloan Kettering’s current clinical trials for adults with MDS. To learn more about a study, choose from the list below.